Literature DB >> 24136078

Targeting IDH: the next big thing in AML.

Mark Levis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24136078     DOI： 10.1182/blood-2013-09-522441

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Acute myeloid leukemia: advancing clinical trials and promising therapeutics.

Authors:  Naval Daver; Jorge Cortes; Hagop Kantarjian; Farhad Ravandi
Journal:  Expert Rev Hematol       Date:  2016-03-17       Impact factor: 2.929

2.  Inhibitors of Mutant IDH for the Treatment of Cancer.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2014-10-07       Impact factor: 4.345

Review 3.  Life after transplant: are we becoming high maintenance in AML?

Authors:  A M Brunner; A T Fathi; Y B Chen
Journal:  Bone Marrow Transplant       Date:  2016-06-20       Impact factor: 5.483

Review 4.  Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.

Authors:  Pankit Vachhani; Prithviraj Bose; Mohamed Rahmani; Steven Grant
Journal:  Physiol Genomics       Date:  2014-05-13       Impact factor: 3.107

5.  Rise of the mutants: report from the 19th conference of the European Haematology Association, Milan, 12-15 June 2014.

Authors:  Luca Mazzarella
Journal:  Ecancermedicalscience       Date:  2014-08-18

Review 6.  Epigenetics in Cancer: A Hematological Perspective.

Authors:  Maximilian Stahl; Nathan Kohrman; Steven D Gore; Tae Kon Kim; Amer M Zeidan; Thomas Prebet
Journal:  PLoS Genet       Date:  2016-10-10       Impact factor: 5.917

Review 7.  Digging deep into "dirty" drugs - modulation of the methylation machinery.

Authors:  Lisa Pleyer; Richard Greil
Journal:  Drug Metab Rev       Date:  2015-01-08       Impact factor: 4.518

8.  Genomic and transcriptomic characterization of skull base chordoma.

Authors:  Jason K Sa; In-Hee Lee; Sang Duk Hong; Doo-Sik Kong; Do-Hyun Nam
Journal:  Oncotarget       Date:  2017-01-03

Review 9.  S100 Proteins in Acute Myeloid Leukemia.

Authors:  Annette K Brenner; Øystein Bruserud
Journal:  Neoplasia       Date:  2018-10-23       Impact factor: 5.715

10.  Thioredoxin reductase is a major regulator of metabolism in leukemia cells.

Authors:  Sheelarani Karunanithi; Ruifu Liu; Yongchun Hou; Giancarlo Gonzalez; Natasha Oldford; Anne Jessica Roe; Nethrie Idipilly; Kalpana Gupta; Chandra Sekhar Amara; Satwikreddy Putluri; Grace Kyueun Lee; Juan Valentin-Goyco; Lindsay Stetson; Stephen A Moreton; Vasanta Putluri; Shyam M Kavuri; Yogen Saunthararajah; Marcos de Lima; Gregory P Tochtrop; Nagireddy Putluri; David N Wald
Journal:  Oncogene       Date:  2021-07-08       Impact factor: 9.867
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.